Speakers


Marieke van Dalen
MARA Consultancy

Dr Cornelia Nopitsch-Mai
formerly Quality Assessor
Objectives
You will get to know
- how to describe manufacturing processes
- how to compile data for drug substance stability, impurities and residual solvents
- which are the important points to consider for US-DMFs
- which are the requirements for Japanese DMFs
- how to handle changes in European, US- and Japanese DMFs
- which are the major differences and advantages of the ASMF and CEP procedure
The European ASMF procedure differs significantly from the US-DMF procedure and for strategic reasons it is very important to take these differences into account.
Moreover, there are particular requirements for DMFs in Japan. For global acting companies it is a big challenge to handle the different procedures of compiling, submitting, changing and maintaining Drug Master Files in an efficient way.
Background
Wed., 07 October 2026, 8.30 h – 16.45 h
Target Group
Technical Requirements
We use Webex for our live online training courses and webinars. At https://www.gmp-compliance.org/training/online-training-technical-information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.
Fees (per delegate plus VAT)
ECA Members € 1,890
APIC Members € 1,990
Non-ECA Members € 2,090
EU GMP Inspectorates € 1,045
The fee is payable in advance after receipt of invoice.
Presentations/Certificate
The presentations will be made available to you prior to the Live Online Training as PDF files. After the event, you will automatically receive your certificate of participation.
Conference language
The official conference language will be English.
Contacts:
Questions regarding content:
Ms Anne Günster (Operations Director) +49(0)62 21/84 44 50, guenster@concept-heidelberg.de
Questions regarding organisation:
Mr Rouwen Schopka (Organisation Manager) +49(0)62 21/84 44 24, schopka@concept-heidelberg.de.
Programme
Seminar Programme as PDF
- Regulatory background and scope
- The revised ASMF Guideline
- Open and closed parts – points to consider
- The worksharing procedure for assessments of ASMFs
- Upcoming European developments: Potential implications of the pharma package
- How to file and use Drug Master Files in the US
- The format and the content of the US Drug Master File
- Specific points to consider for the US Drug Master File
- Question-based review: some US specifics
- How to provide CMC Information
- CTD guidance: contents of the file
- Differences in interpretation
- Guidelines
- Impact of the new guidelines ICH Q3D and ICH M7
- Sources of Impurities
- Setting and justification of specifications
- Residual solvents, solvent classes
- Content and scope of data – documentation requirements
- Frequent mistakes
- Description of the manufacturing process
- Active substance starting material
- Critical steps in the Synthesis
- Process validation for active substances
- Case studies
- What guidance to use
- Types of changes in the US guidance and the procedures around it
- How to classify a change in the US
- Link to the FDA inspection program
- Why is there a need for changes?
- Types of changes
- How to communicate with the MA holders and how to get feed back
- Differences between ASMF and CEP
- When to implement a specific change
- Version management of the ASMF
- The certification scheme of the Ph.Eur.
- Handling of variations in the CEP procedure
- Advantages and disadvantages of the CEP procedure compared to the ASMF procedure
- When to use a CEP or an ASMF in an MAA
- Stability guidelines
- Stability testing of new drug substances and drug product
- Storage conditions
- Bracketing and matrixing designs
- Stability data from new drug dosage forms
- How to document evaluation of stability data
- Optimising the submission
- File procedure and change control procedure in Japan
- Regulatory procedures in Japan:
- Site accreditation
- GMP paper- based inspection
- Drug Master File
- Drug Master File Format
- Specific points to consider for the J-DMF
- Change procedures and communication with the Japanese authority
- Types of changes
- Notification of changes
This course is part of the GMP Certification Programme "ECA Certified Regulatory Affairs Manager" Learn more
| ECA-Member*: | € 1890,- |
| Non ECA Member*: | € 2090,- |
| EU/GMP Inspectorates*: | € 1045,- |
| APIC Member Discount*: | € 1990,- |
(All prices excl. VAT). Important notes on sales tax.
not available
not available
Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org
- Our Service
Testimonials
Your Certificate
Seminar Programme as PDF